• Molecular NamePimozide
  • SynonymPimozida [INN-Spanish]; Pimozidum [INN-Latin]
  • Weight447.529
  • Drugbank_IDDB01100
  • ACS_NO2062-78-4
  • Show 2D model
  • LogP (experiment)6.3
  • LogP (predicted, AB/LogP v2.0)5.36
  • pka7.3
  • LogD (pH=7, predicted)4.3
  • Solubility (experiment)0.01 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-4.81
  • LogSw (predicted, AB/LogsW2.0)0.0
  • Sw (mg/ml) (predicted, ACD/Labs)0.0
  • No.of HBond Donors1
  • No.of HBond Acceptors4
  • No.of Rotatable Bonds6
  • TPSA35.58
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyAn antipsychotic drug.
  • Absorption_value70.0
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability40.0
  • Protein binding99.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmHepatic, by cytochrome P450, isoenzymes 3A, and 1A2; metabolites are inactive
  • Half life2 days
  • Excretionurine, and to a lesser extent in feces
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)LD50=1100 mg/kg
  • LD50 (mouse)LD50=228 mg/kg